CSL Ltd (CMXHF)
187.50
-1.00
(-0.53%)
USD |
OTCM |
Jun 17, 14:01
CSL Price to Book Value: 5.275 for June 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
June 14, 2024 | 5.303 |
June 13, 2024 | 5.402 |
June 12, 2024 | 5.247 |
June 11, 2024 | 5.213 |
June 10, 2024 | 5.276 |
June 07, 2024 | 5.317 |
June 06, 2024 | 5.402 |
June 05, 2024 | 5.191 |
June 04, 2024 | 5.268 |
June 03, 2024 | 5.317 |
May 31, 2024 | 5.317 |
May 30, 2024 | 5.196 |
May 29, 2024 | 5.262 |
May 28, 2024 | 5.162 |
May 24, 2024 | 5.093 |
May 23, 2024 | 5.136 |
May 22, 2024 | 5.136 |
May 21, 2024 | 5.114 |
May 20, 2024 | 5.222 |
May 17, 2024 | 5.199 |
May 16, 2024 | 5.345 |
May 15, 2024 | 5.206 |
May 14, 2024 | 5.092 |
May 13, 2024 | 5.060 |
May 10, 2024 | 5.071 |
Date | Value |
---|---|
May 09, 2024 | 5.113 |
May 08, 2024 | 5.113 |
May 07, 2024 | 5.104 |
May 06, 2024 | 4.995 |
May 03, 2024 | 5.066 |
May 02, 2024 | 4.957 |
May 01, 2024 | 4.957 |
April 30, 2024 | 4.973 |
April 29, 2024 | 4.956 |
April 26, 2024 | 4.946 |
April 25, 2024 | 5.020 |
April 24, 2024 | 5.020 |
April 23, 2024 | 4.952 |
April 22, 2024 | 4.952 |
April 19, 2024 | 4.874 |
April 18, 2024 | 4.874 |
April 17, 2024 | 4.854 |
April 16, 2024 | 4.923 |
April 15, 2024 | 5.085 |
April 12, 2024 | 5.085 |
April 11, 2024 | 5.085 |
April 10, 2024 | 5.296 |
April 09, 2024 | 5.143 |
April 08, 2024 | 5.079 |
April 05, 2024 | 5.071 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.445
Minimum
Nov 01 2023
16.83
Maximum
Dec 11 2019
9.768
Average
10.98
Median
Price to Book Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 1.727 |
Immutep Ltd | -- |
Opthea Ltd | -- |
Price to Book Value Related Metrics
PE Ratio | 36.84 |
PS Ratio | 6.483 |
PEG Ratio | 187.13 |
Price | 187.50 |
Earnings Yield | 2.71% |
Market Cap | 90.61B |
PEGY Ratio | 24.40 |
Operating PE Ratio | 36.04 |
Normalized PE Ratio | 36.84 |